Peter MacCallum Cancer Centre

HAPPY 20TH BIRTHDAY AYA!!!! Supercars driver and Peter Mac patient Thomas Randle sat down with the Herald Sun to talk about the Victorian Adolescent & Young Adult Cancer Service which is celebrating two decades this week. The AYA service, based at Peter Mac, is a leader in the delivery of youth-friendly and youth-responsive healthcare to young people 15-25. Thomas has been a huge champion for both Peter Mac and young cancer patients, serving on the Youth Cancer Action Board to help shape services and experiences for young people. You can read the full story via the Herald Sun: https://lnkd.in/g5fhfvr4

Carn The Bloods!!! The mighty Peter Mac Bloods football team have defended their title and gone back-to-back in the 2024 Medical Research Institute Cup! The team defeated sides from WEHI and the St Vincent's Institute to secure this year’s prize at windy Western Oval in Parkville. They were led to victory by Peter Mac researchers and coaches Patrick Crock, Hugh Chalmers and Will Tobin. “It was a huge thrill to go back to back!” Patrick said. “The day is a great opportunity to meet researchers from different organisations as well as getting to know staff from Peter Mac in a different way." Read more: https://lnkd.in/ejMRJWcH

Peter Mac's Centre of Excellence in Cellular Immunotherapy is producing a comprehensive CAR T-cell Therapy Preceptorship, to take place at Parkville on October 17 and 18. An entirely free event, thanks to sponsorship from Gilead Kite, the event will focus on the challenges multidisciplinary teams face when delivering this groundbreaking treatment. Several Peter Mac experts and some special guest speakers will explore patient selection, bridging treatment and side effects, with an emphasis on providing excellent patient care

Peter Mac's Professor Michael Hofman joined 2GB this week to talk about the first targeted nuclear medicine for men with prostate cancer to be approved by the TGA, Pluvicto. Professor Hofman, who leads our ProsTIC Theranostics, says this is a welcome new addition to treatment options for men with advanced prostate cancer. Listen to Professor Hofman's interview below or read more from the Prostate Cancer Foundation of Australia here: https://lnkd.in/gQJfYSDx

Peter Mac's Dr Jamie Kuzich has received the American Society of Hematology (ASH) 2024 Global Research Award - one of just of 11 awarded to early career investigators from around the globe. Dr Kuzich, a clinical haematologist completing the final year of his doctoral studies in Professor Mark Dawson's lab, will use the funding to further explore his project into improving chimeric antigen receptor (CAR) T cell therapy using sophisticated tools to identify, trace and profile "persister cells" that survive the immunotherapy treatment. Watch the video below to hear from Dr Kuzich or read more here: https://lnkd.in/guZbQYea

Peter Mac researchers have been awarded three significant National Health and Medical Research Council (NHMRC) grants totalling $9 million to drive forward innovative approaches in cancer treatment, lymphatic health and antimicrobial stewardship. The three NHMRC Centres of Research Excellence grants will be led by Professor Monica Slavin, Professor Ben Hogan and Professor Professor Karin (Kas) Thursky. Read more 👇

We're so proud to be part of this amazing Parkville community, where love, acceptance, and equality are at the heart of everything we do! Today we stand in solidarity with LGBTQIA+ youth everywhere on #WearItPurple Day - and we're here to let you know that you're seen and safe when visiting the Parkville precinct. Huge thanks to our colleagues from The Royal Melbourne Hospital, The Royal Women's Hospital and WEHI (Walter and Eliza Hall Institute of Medical Research), for joining us to light up the Peter Mac foyer in a sea of purple. #WearItPurple #Inclusion #LGBTQIA #Support #equalityforall

Tahli, mum of two, describes CAR-T cell therapy as her miracle. For her, the life-saving cancer treatment by researchers at Peter MacCallum Cancer Centre, including A/Prof Jane Oliaro and team, has been nothing short of remarkable. Here is Tahli and Jane's story and why supporting the full costs of research is pivotal to keeping the foundations of our Victorian medical research institutes strong so they may continue their vital work. Ben Carroll Georgie Crozier MP Ricky Johnstone

Professor Geoffrey Lindeman and Professor Jane Visvader have jointly received one of the world’s oldest science prizes from the UK’s The Royal Society. Profs Lindeman and Visvader are Joint Head of the Breast Cancer Laboratory at the WEHI (Walter and Eliza Hall Institute of Medical Research) in Melbourne. As a clinician-scientist, Prof Lindeman is also a medical oncologist at the Peter MacCallum Cancer Centre and The Royal Melbourne Hospital. They are recognised for their discoveries around breast stem and progenitor cells, which have supported new approaches to breast cancer treatment and prevention. “We are cognisant that science is very much a ‘team sport’, and that this award really recognises a stellar team of devoted scientists and colleagues and patient advocates, who we have been fortunate to work with over the last 25 years,” they said in a joint statement on Wednesday. Read more 👇

Peter Mac's Professor Kieran Harvey helped discover the ‘Hippo’ signalling pathway 20 years ago. He's spent his career trying to understand more about how this ancient pathway controls organ growth and how we can target it to treat mesothelioma - a devastating #cancer that has few effective treatments and a very poor prognosis.   There are currently five treatments being tested in early clinical trials that target the Hippo pathway and most of these are being trialled as mesothelioma treatments, because the Hippo pathway is the driving force behind this particular cancer.  “These new treatments work by inhibiting TEAD, a type of protein that helps control organ growth, however people will likely develop resistance to the treatment so we have been researching ways to stop this from occurring,” Prof Harvey explains. Read more about his study published in EMBO Reports  👇